Among a slew of emerging artificial intelligence biotech companies, BigHat has the potential to transform how next-generation antibodies are designed,...
Competitive pressure and a pause in manufacturing due to routine maintenance have pushed US sales of Abecma (idecabtagene vicleucel), Bristol Myers Squibb...
Bacteriophages, also called phages, are viruses that infect and kill bacteria, their natural hosts. But from a macromolecular viewpoint, phages can be...
Bristol Myers Squibb is facing several questions about its mid-term future after it delayed sales projections for its new product portfolio, which includes...
The Global Coalition for Adaptive Research (GCAR) in collaboration with the University of Pittsburgh and UPMC, on behalf of the REMAP-CAP Investigator...
Following a national search, Paul Anderson, MD, PhD, has been named Chief Academic Officer for Mass General Brigham. Anderson, who has been serving in...
Hepatoblastoma is the most frequent liver cancer in childhood. Despite the advances in its combined treatment involving surgery and chemotherapy, this...
The promise of human organotypic tissues for tissue development, disease modelling, and drug testing is widely recognized, but limitations around cell...
Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and Beijing Chaoyang Hospital have developed a new “pseudo...
MADRID — Roche on Saturday touted additional data from a study showing that its drug Alecensa offers “unprecedented” disease-free survival in patients...
MADRID — Seagen and Astellas Pharma drew a standing ovation from thousands of ESMO delegates on Sunday as the companies unveiled further data from a...
MADRID — Roche on Saturday touted additional data from a study showing that its drug Alecensa offers “unprecedented” disease-free survival in patients...
MADRID — Seagen and Astellas Pharma drew a standing ovation from thousands of ESMO delegates on Sunday as the companies unveiled further data from a...
The Alliance for Clinical Trials in Oncology today announced detailed results will be presented at ESMO 2023 from CABINET (A021602), a phase III pivotal...
The US Food and Drug Administration has reported that the decongestant phenylephrine, taken in oral form, does not work.
Grandma swore by it. Now science weighs in on the healing powers of chicken soup.
The COVID Gravy Train Is Over: Pfizer & Moderna Shares Down 35% & 49% This Year It took what felt like forever, but at least some reality...
Cyrus Harmon → Ex-Olema Oncology chief Cyrus Harmon has resurfaced as CEO of Vilya, a Seattle-based macrocycle biotech from David Baker’s lab that...
1,000 Days Without A Trial: Jan. 6 Prisoner Shares His Story of 'Endurance, Perseverance, And Hope' Authored by Patricia Tolson via The Epoch...
Johnson & Johnson is ramping up manufacturing capacity for the CAR-T therapy it developed with Legend Biotech, driven by high demand for the Carvykti,...
Half a million new mothers in the US suffer from postpartum depression every year, yet a lack of awareness and stigma toward the condition keep many...
Digital health tools and technologies were thrust into the spotlight during the pandemic and were able to help many people get much needed medical advice...
In this GEN webinar, our distinguished speaker Dr. Simon Gregory from the Duke Molecular Physiology Institute will demonstrate how 10x Genomics’ Xenium...
The first AI-designed drugs have ended with disappointment. Over the last year-plus, the first handful of molecules created by artificial intelligence...
Johnson & Johnson is ramping up manufacturing capacity for the CAR-T therapy it developed with Legend Biotech, driven by high demand for the Carvykti,...
As Lonza unveiled its four-year financial predictions on Tuesday, observers were left unsure about the CDMO’s cell and gene therapy (CGT) forecast. Nonetheless,...
Researchers at the University of Bath in the United Kingdom have developed a shape-shifting ball that can inflate and deflate in response to someone’s...
The fusion of artificial intelligence (AI)-enabled technologies and precision oncology is advancing at an unprecedented pace, and the introduction of the...
Cytiva and Bayer share a vision of the challenges limiting the advancement of allogeneic cell therapy and believe that together they can overcome these...
Michelle Teng, CEO and co-founder of Etcembly and co-founder of SynaptixBio, spoke with Inside Precision Medicine's senior editor Helen Albert about her...